In Oceania, drug production, trafficking and consumption remain overwhelmingly a criminal justice issue. However, Australia and New Zealand have moved towards policies that prioritise health to respond to drug use. More recently, New Zealand made the headlines with the adoption of an innovative policy towards new psychoactive substances.
Prof. Alison Ritter argues that the substantial sums of money poured into law enforcement to reduce drug consumption are ineffectual. Rather, we should invest "continuously evaluated, evidence-based policies and programs”.
Bluelight, a new site for swapping information about drug batches, aims to fill the gap left by a lack of formal quality control. This can raise awareness of contaminants and variable purity within the drugs currently in circulation.